<DOC>
	<DOCNO>NCT01069081</DOCNO>
	<brief_summary>The objective study evaluate efficacy tolerability high dose proton pump inhibitor combine chemotherapy metastatic breast cancer .</brief_summary>
	<brief_title>Docetaxel Cisplatin Chemotherapy With Without High Dose Proton Pump Inhibitor Metastatic Breast Cancer</brief_title>
	<detailed_description>High dose proton pump inhibitor ( PPI ) prove beneficial improve efficacy combine chemotherapy preclinical clinical trials.This study design explore whether add proton pump inhibitor docetaxel cisplatin chemotherapy improve efficacy affect tolerability metastatic breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Signed informed consent . Female , ≥ 18 year . Histologically confirm invasive breast cancer . Metastatic breast cancer . Karnofsky Performance Status ≥60 . Life expectancy 3 month . Subject must adequate organ function . Normal laboratory value : hemoglobin &gt; 80g/dl , neutrophil &gt; 2.0×10^9/L , platelet &gt; 80×10^9/L , serum creatinine &lt; upper limit normal ( ULN ) , serum bilirubin &lt; ULN , ALT AST &lt; 2.5×ULN , AKP &lt; 5×ULN . Negative serum pregnancy test woman childbearing potential . Good condition infusion willing phlebotomy throughout whole study . Have cease antitumor treatment include endocrinotherapy biotargeted therapy 28 day . Have least one target lesion accord Response Evaluation Criteria Solid Tumors ( RECIST ) criterion . No prior use docetaxel use docetaxel adjuvant/neoadjuvant chemotherapy relapse free survival least 12 month . Pregnant lactating female . History malignancy . However , subject diseasefree 5 year , subject history completely resect nonmelanoma skin cancer successfully treat situ carcinoma eligible . Concurrent disease condition would make subject inappropriate study participation , serious medical disorder would interfere subject 's safety . Active uncontrolled infection . Known history uncontrolled symptomatic angina , arrhythmia , congestive heart failure . Concomitant brain metastasis . Have receive chemotherapy metastasis .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Metastasis Breast Cancer</keyword>
	<keyword>Proton Pump Inhibitor</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Phase II study</keyword>
	<keyword>TTP</keyword>
</DOC>